Author

David J. Warren 1

1 Oslo University Hospital, Oslo, Norway

​FOUR SARS-COV-2 VACCINE DOSES OR HYBRID IMMUNITY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPIES. A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

Kristin H Bjørlykke, Hilde S. Ørbo, Anne T. Tveter, Trung T. Tran, Joseph Sexton, Ingrid Jyssum, Ingrid E. Christensen, Grete Kro, Tore K Kvien, Jørgen Jahnsen, Ludvig A. Munthe, Adity Chopra, David J. Warren, Gunnveig Grødeland, Espen A Haavardsholm, Siri Mjaaland, Sella A. Provan, John T. Vaage, Silje W. Syversen, Guro

IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Kristin Hammersbøen Bjørlykke, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Ingrid E. Christensen, Trung T. Tran, Siri Mjaaland, David J. Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jørgen Jahnsen, Ludvig A. Munthe, Espen A Haavardsholm, Gunnveig Grødeland, John Torgils Vaage, Sella Aarrestad Provan, Gur

SEROLOGIC RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNOSUPPRESSIVE THERAPY: ASSOCIATION TO DISEASE TYPE AND SERUM DRUG LEVELS

Kristin Kaasen Jørgensen, Marte Lie Høivik, Adity Chopra, Jūratė Šaltytė Benth, Petr Ricanek, Bjorn Moum, Ingrid Jyssum, Nils Bolstad, David J. Warren, John Torgils Vaage, Ludvig Andre Munthe, Knut E.A. Lundin, Karoline Anisdahl, Silje W. Syversen, Guro Lovik Goll, Fridtjof Lund-Johansen, Asle W. Medhus, Jørgen Jahnsen

Item 1 - 3 / 3
1